Bio-Rad Laboratories, Inc. Stock Nyse
Equities
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
279.9 USD | 0.00% | 0.00% | -12.71% |
Financials (USD)
Sales 2024 * | 2.71B | Sales 2025 * | 2.86B | Capitalization | 7.89B |
---|---|---|---|---|---|
Net income 2024 * | 444M | Net income 2025 * | 509M | EV / Sales 2024 * | 2.66 x |
Net cash position 2024 * | 661M | Net cash position 2025 * | 1.24B | EV / Sales 2025 * | 2.33 x |
P/E ratio 2024 * |
18.1
x | P/E ratio 2025 * |
15.8
x | Employees | 8,030 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66% |
Latest transcript on Bio-Rad Laboratories, Inc.
Current month | -15.74% | ||
1 month | -14.40% | ||
3 months | -13.51% | ||
6 months | +2.53% | ||
Current year | -12.71% |
Managers | Title | Age | Since |
---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 74 | 88-12-31 |
Gregory Hinckley
DFI | Director of Finance/CFO | 77 | 83-01-31 |
Andrew Last
COO | Chief Operating Officer | 64 | 19-04-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Edwards
BRD | Director/Board Member | 64 | 17-04-24 |
Alice Schwartz
FOU | Founder | 97 | 51-12-31 |
Gregory Hinckley
BRD | Director/Board Member | 77 | 17-04-24 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- BIO Stock
- BIO.B Stock